Institutional investors purchased a net $3.3 million shares of KURA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 103.98% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF PARTNERS LP Bought 343.3 Thousand shares of Kura Oncology Inc
HENNION & WALSH ASSET MANAGEMENT... Bought 6.4 Thousand shares of Kura Oncology Inc
MIRAE ASSET GLOBAL INVESTMENTS C... Bought 11.00 shares of Kura Oncology Inc